Sell: Cytec (CYT)
from 2 for 1 Stock Split Newsletter
Updated from Investment Digest 763, November 19, 2014
On 7/29, Cytec (CYT) was “in play” because of a buyout announcement and its stock price
immediately jumped about 26%. The buyer, Solvay, is a Belgian company not traded on the US exchanges.
Rather than waiting to determine if the buyout would be in cash or for Solvay stock, our position
in Cytec was sold immediately.
ID Editor’s Note: This stock was recommended in ID at $49.71; current price as this goes to press is $74.10, a 49.1% gain.
Neil Macneale, 2 for 1 Stock Split Newsletter, www.2-for-1.com, 408-210-6881, August 14, 2015